Clorox Company (The) (CLX) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Clorox Company (The)

NYSE•Consumer Defensive•Household & Personal Products

$92.68+2.78(0.03%)Market open

Market Cap

$10.69B

P/E

18.2x

P/S

1.6x

P/B

118.8x

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company home care cleaning and disinfecting products and laundry additives, skin sanitization and cleaning products, professional cleaning and disinfecting products, and professional food service products under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Formula 409, Purell, GOJO, CloroxPro, Clorox Healthcare, Hidden Valley, Poett, Clorinda, and Chux brands. It also provides bags and wraps, cat litter, and grilling products under the Glad, Fresh Step, Scoop Away, Kingsford, and Ever Clean brands; and dressings, dips, seasonings, sauces, water-filtration products, and natural personal care products under the Brita and Burt's Bees brands. The company sells its products through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet, and military stores; third-party and owned e-commerce channels; distributors; and other retail outlets through direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.

How this company scores

AverageMetricSide Score: 43/100

Strongest: Profitability (16/25); weakest: Growth (5/25).

Profitability16/25

Growth5/25

Balance Sheet & Red Flags9/25

Cash & Earnings Quality13/25

Strengths

Strong marginsHigh ROEInterest easily coveredNo share dilution

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 18.2x5y range 16.2x – 258.1x

Currently below its 20-quarter median.

P/S · 1.6x5y range 1.6x – 3.0x

Currently below its 20-quarter median.

P/B · 118.8x5y range 30.9x – 6365.5x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Watch

Operating margins declined 10.1% — watch for continued compression, which may signal competitive or cost pressure.

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Price & Volume

Market Cap $10.69B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $6.72B
Q. Revenue: $1.95B
TTM EBITDA: $2.02B
TTM Op. Income: $1.78B
Q. Op. Income: $506.00M
TTM Net Income: $587.00M
Q. Net Income: $163.00M
EPS: $1.309
Shares Out.: $121.51M

$6.72B in TTM revenue declined 5.4% YoY, reaching $1.95B last quarter. TTM EBITDA of $2.02B and TTM operating income of $1.78B show growth is flowing through to the bottom line. TTM net income of $587.00M means revenue is converting into profit. Over the past year, TTM revenue is down 5% — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 41.3%
EBITDA Margin: 30.0%
Op. Margin: 26.0%
Net Margin: 8.4%

Op. margin of 26.0% is down 5.6% YoY — costs are rising relative to revenue. Net margin at 8.4% and gross margin of 41.3% show how much of each revenue dollar survives to profit. Over the past year, operating margin is down 18% — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 18.2x
P/S Ratio: 1.6x
P/B Ratio: 118.8x

At 18.2x P/E, the stock trades within typical market levels. P/S of 1.6x and P/B of 118.8x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has risen for 2 consecutive quarters — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $7.79B
Cash: $143.00M
Long-Term Debt: $3.98B
Book Value: $90.00M
D/E Ratio: 44.2
Debt/EBITDA: 6.8

With $7.79B in assets and $3.98B in long-term debt, D/E is 44.2and book value is $90.00M — elevated leverage, meaning significant financial risk in a downturn. Over the past year, debt/equity is up 0% — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $330.00M
TTM Free Cash Flow: $405.00M
FCF Margin: 6.0%
FCF / Net Income: 0.7

TTM FCF of $405.00M on $330.00M in operating cash flow. The FCF / Net Income ratio of 0.7x means cash covers only part of net income — earnings quality needs attention. Over the past year, free cash flow is down 47% — an improving trend.